Cannabidiol (CBD), a compound that is not psychoactive and is obtained from the cannabis sativa plant, has increasingly gained attention in recent years with the possibilities of its therapeutic value, most especially in cancer treatment. Although CBD should not be associated with curing cancer, new studies indicate that this compound could be useful while undergoing cancer treatment, and reducing side effects including the growth and spread of cancer. Thanks to companies such as Shango, these revolutionary treatments are being made available as part of healthcare and wellness.
Analysis of Pain Management and Symptom Modulation
CBD works with the endocannabinoid system for controlling pain and inflammation. To relieve the pain-inflamed and/or nauseated patients during chemotherapy, CBD is expected to attach to any cannabinoid receptors and ease the pain that induces vomiting and/or neuropathic pain in cancer patients undergoing chemotherapy.
Diminished Side Effects of Chemotherapy
Many types of cancer can be effectively cured through Chemotherapy. However, it also brings about a lot of side effects such as, but not limited to, nausea, vomiting, lack of eating desire, exhaustion, and so on. Other researchers, however, have indicated that CBD can reduce nausea and even stimulate hunger, which is why it is often added to the treatment of cancer. The National Cancer Institute has approved the use of Cannabidiol to relieve chemotherapy-induced vomiting and nausea.
Activity Against Cancer
Although research remains in its infancy, preliminary investigations have indicated that CBD might have anti-tumor activity. Preclinical studies have demonstrated that CBD can retard the proliferation of certain cancers by inducing apoptosis and preventing metastasis CBD has also been noted to act with other anticancer modalities, as it may augment their actions.
The Role of Companies such as Shango in Promoting CBD
Notably, Shango is engaged in efforts to underscore the importance of CBD–based medication and its usefulness to cancer patients. As there appears to be an orientation towards the use of cannabis for medicinal purposes, Shango is now working on the formulation of management regimes for patients with cancer that will incorporate either CBD, THC, or both combined. From oils to topicals, these products provide people with a safe and effective way to add CBD to their care plans for cancer.
Shango also attempts to educate people and work with medical professionals, which indicates the increasing willingness to include CBD in cancer treatment modalities. Shango focuses on quality and consistency and is helping facilitate the acceptance of CBD as medicine in the healthcare sector.
There is a need for many more clinical features to evaluate the contribution of CBD in cancer treatment properly. However, there is already CBD with the potential for symptom relief, management of pain, and even cancer cell inhibition. This introduces companies such as Shango, which are at the forefront of making these products available to patients. This provides great hope for those who are in search of alternative or supplementary cancer treatments. The future may see CBD as a core chemistry in the management of cancer diseases, benefiting many patients who have the disease and are struggling to live.
